Tumor-derived vascular endothelial growth factor (VEGF)-A facilitates tumor metastasis through the VEGF-VEGFR1 signaling pathway

International Journal of Oncology

Volumn 39, Issue 5, 2011, Pages 1213-1220

  Liu, Wenbo ^a   Xu, Jiying ^a   Wang, Mingming ^a   Wang, Qiangxiu ^a   Bi, Yuli ^a   Han, Mingyong ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Metastasis; Signal pathway; Vascular endothelial growth factor; VEGFR

Indexed keywords

BEVACIZUMAB; DOCETAXEL; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CARCINOMA CELL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR VOLUME;

ADULT; AGED; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, SCID; MIDDLE AGED; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80053189056     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1138     Document Type: Article

References (34)

1. Ferrara N, Gerber HP and LeCouter J: The biology of VEGF and its receptors. Nat Med 9: 669-676, 2003. (Pubitemid 36749215)
2. Ferrara N: The role of VEGF in the regulation of physiological and pathological angiogenesis. EXS 94: 209-231, 2005.
3. Sato Y, Kanno S, Oda N, Abe M, Ito M, Shitara K and Shibuya M: Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction. Ann NY Acda Sci 902: 201-205, 2000.
4. Lohela M, Bry M, Tammela T and Alitalo K: VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 21: 154-165, 2009.
5. Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S, Ferrara N, Nagy A, Roos KP and Iruela-Arispe ML: Autocrine VEGF signaling is required for vascular homeostasis. Cell 130: 691-703, 2007. (Pubitemid 47268059)
6. Fukasawa M and Korc M: Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines. Clin Cancer Res 10: 3327-3332, 2004. (Pubitemid 38685437)
7. Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
8. Ferrara N: Role of myeloid cells in vascular endothelial growth factor independent tumor angiogenesis. Curr Opin Hematol 17: 219-224, 2010.
9. Geiger TR and Peeper DS: Metastasis mechanisms. Biochim Biophys Acta 1796: 293-308, 2009.
10. Jechlinger M, Sommer A, Moriggl R, Seither P, Kraut N, Capodiecci P, Donovan M, Cordon-Cardo C, Beug H and Grünert S: Autocrine PDGFR signaling promotes mammary cancer metastasis. J Clin Invest 116: 1561-1570, 2006.
11. Fidler IJ: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458, 2003.
12. Yang J and Weinberg RA: Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14: 818-829, 2008. (Pubitemid 351757205)
13. Pantel K, Brakenhoff RH and Brandt B: Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8: 329-340, 2008. (Pubitemid 351596394)
14. Caceres W and Gonzalez S: Angiogenesis and cancer: recent advances. PR Health Sci J 22: 149-151, 2003.
15. Carmeliet P: Angiogenesis in life, disease and medicine. Nature 438: 932-936, 2005.
16. Maharaj AS, Saint-Geniez M, Maldonado AE and D'Amore PA: Vascular endothelial growth factor localization in the adult. Am J Pathol 168: 639-648, 2006. (Pubitemid 43271161)
17. Bjorndahl MA, Cao R, Burton JS, Brakenhielm E, Religa P, Galter D, Wu L and Cao Y: Vascular endothelial growth factor-A promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res 65: 9261-9268, 2005. (Pubitemid 41507992)
18. Weis S, Cui J, Barnes L and Cheresh D: Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J Cell Biol 167: 223-229, 2004. (Pubitemid 39435066)
19. Lee YH, Tokunaga T, Oshika Y, Suto R, Yanagisawa K, Tomisawa M, Fukuda H, Nakano H, Abe S, Tateishi A, Kijima H, Yamazaki H, Tamaoki N, Ueyama Y and Nakamura M. Cell retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma. Eur J Cancer 35: 1089-1093, 1999. (Pubitemid 29339192)
20. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF and Detmar M: VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201: 1089-1099, 2005. (Pubitemid 40524677)
21. Saito DM, Franco MR, Parra ER, Ab'saber AM, Farhat C, Eher E, Soufen MA, Rodrigues R, Capelozzi VL: Cell cycle regulator in primary lung adenocarcinoma and its haematogenous metastases. Histopathology 50: 525-527, 2007. (Pubitemid 46328184)
22. Alitalo K, Tammela T and Petrova TV: Lymphangiogenesis in development and human disease. Nature 438: 946-953, 2005. (Pubitemid 43093960)
23. Yang SY, Yu H, Krygier JE, Wooley PH and Mott MP: High VEGF with rapid growth and early metastasis in mouse osteosarcoma model. Sarcoma 2007: 95628, 2007.
24. Sullivan R and Graham CH: Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev 26: 319-331, 2007. (Pubitemid 47101665)
25. Ferrara N and Kerbel RS: Angiogenesis as a therapeutic target. Nature 438: 967-974, 2005. (Pubitemid 43093963)
26. Takahashi H and Shibuya M: The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clinical Science 109: 227-241, 2005. (Pubitemid 41337127)
27. Decaussin M, Sartelet H, Robert C, Moro D, Claraz C, Brambilla C and Brambilla E: Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF- R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival. J Pathol 188: 369-377, 1999. (Pubitemid 29327434)
28. Kaya M, Wada T, Akatsuka T, Kawaguchi S, Nagoya S, Shindoh M, Higashino F, Mezawa F, Okada F and Ishii S: Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res 6: 572-577, 2000. (Pubitemid 30111481)
29. Sharieff W: Bevacizumab in colorectal cancer. N Engl J Med 351: 1690-1691, 2004.
30. Hirsh V: Systemic therapies in metastatic non-small cell lung cancer with emphasis on targeted therapies: the rational approach. Curr Oncol 17: 13-23, 2010.
31. Hiratsuka S, Nakamura K, Iwai S, Murakami M, Itoh T, Kijima H, Shipley JM, Senior RM and Shibuya M: MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2: 289-300, 2002. (Pubitemid 41043963)
32. Hiratsuka S, Nakao K, Nakamura K, Katsuki M, Maru Y and Shibuya M: Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice. Mol Cell Biol 25: 346-354, 2005. (Pubitemid 40039824)
33. Zhang D, Li B, Shi J, Zhao L, Zhang X, Wang C, Hou S, Qian W, Kou G, Wang H and Guo Y: Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor- immunoglobulin fusion protein. Cancer Res 70: 2495-2503, 2010.
34. Lin J, Lalani AS, Harding TC, Gonzalez M, Wu WW, Luan B, Tu GH, Koprivnikar K, VanRoey MJ, He Y, Alitalo K and Jooss K: Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor. Cancer Res 65: 6901-6909, 2005. (Pubitemid 41060729)